306 Journal of Medicinal Chemistry, 2007, Vol. 50, No. 2
Romero et al.
(11) Bozzo, C.; Pujol, M. D. Study of Preparation of Methylfuro[3,4-b]-
[1,4]benzodioxinones as Intermediates for the Synthesis of Substituted
Polycyclic Systems. Importance of the Acid Used as Catalyst.
Tetrahedron 1999, 55, 11843-11852.
(12) Bozzo, C.; Pujol, M. D. Intermolecular Diels-Alder Cycloadditions
of Isobenzofuran: A Synthesis of Fused Heterocycles. Heterocycl.
Commun. 1996, 2, 163-167.
function, FCP(r) displays the largest common pattern (LCP) for the
two molecules A and B.
Acknowledgment. The authors express their gratitude to the
Laboratoires Servier (France), Ministerio de Ciencia y Tecno-
log´ıa (MCYT, BQU 2002-00148) and to the Generalitat de
Catalunya, Spain (SGR2005-00180), for financial support.
(13) (a) Gribble, G. W.; Saulnier, M. G.; Sibi, M. P.; Obaza-Nutaitis, J.
A. Synthesis and Diels-Alder Reactions of 1,3-Dimethyl-4-(phenyl-
sulfonyl)-4H-furo[3,4-b]indole. A New Annulation Strategy for the
Construction of Ellipticine and Isoellipticine. J. Org. Chem. 1984,
49, 4518-4523. (b) Smith, J. G.; Welankiwar, S. S.; Shantz, B. S.;
Lai, E. H.; Chu, N. G. Synthetic Routes to Derivatives of Polycyclic
Aromatic Hydrocarbons Using Isobenzofurans as Transient Reactive
Intermediates. J. Org. Chem. 1980, 45, 1817-1824. (c) Newman,
M. S.; Cells, J. A. A General Route to 2,3-Diacyl-1,4-dihydro-1,4-
disubstituted-1,4-epoxynaphtahlenes and 1,4-Disubstituted 2,3-Naph-
tahlic Anhydrides. J. Org. Chem. 1973, 38, 3482-3487.
(14) (a) Auclair, C. Multimodal Action of Antitumor Agents on DNA:
The Ellipticine Series. Arch. Biochem. Biophys. 1987, 259, 1-14.
(b) Schwaller, M.-A.; Dodin, G.; Aubard, J. Thermodynamics of
Drug-DNA Interactions: Entropy-Driven Intercalation and Enthalpy-
Driven Outside Binding in the Ellipticine Series. Biopolymers 1996,
50, 510-527. (c) Mauffret, O.; Rene, B.; Convert, O.; Monnot, M.;
Lescot, E.; Fernandjian, S. Drug-DNA Interactions: Spectroscopic
and Footprinting Studies of Site and Sequence Specificity of
Elliptinium. Biopolymers 1991, 31, 1325-1341.
(15) (a) Dodin, G.; Schwaller, M. A.; Aubard, J.; Paoletti, C. Binding of
Ellipticine Base and Elliptinium Cation to Calf-Thymus DNA. A
Thermodynamic and Kinetic Study. Eur. J. Biochem. 1988, 176,
371-376. (b) Aubard, J.; Levi, G.; Pantigny, J.; Marsault, J. P.;
Dodin, G.; Schwaller, M. A. SERS of Ellipticine and Derivatives
Free and Bound to DNA. Spec. Publ.sR. Soc. Chem. 1991, 94, 385-
386. (c) Canals, A.; Purciolas, M.; Aymani, J.; Coll, M. The
Anticancer Agent Ellipticine Unwinds DNA by Intercalative Binding
in an Orientation Parallel to Base Pairs. Acta Crystallogr., Sect. D
2005, 61 (7), 1009-1012. (d) Cirino, J. J. V.; Belletato, P.; Dantas,
S.; Ribeiro, L.; Ferreira, G. R.; dos Santos, H. F. Structure and
Properties of Ellipticines. Quim. NoVa 2005, 28, 30-36.
(16) (a) Bermejo, A.; Andreu, I.; Suvire, F.; Le´once, S.; Caignard, D. H.;
Renard, P.; Pierre, A.; Enriz, R. D.; Cortes, D.; Cabedo, N. Synthesis
and Antitumor Targeting G1 Phase of the Cell Cycle of Benzoyldihy-
droisoquinolines and Related 1-Substituted Isoquinolines. J. Med.
Chem. 2002, 45, 5058-5068. (b) Melliou, E.; Magiatis, P.; Mitaku,
S.; Skaltsounis, A.-L.; Pierre´, A.; Atassi, G.; Renard, P. 2,2-Dimethyl-
2H-anthra[2,3-b]pyran-6,11-diones: A New Class of Cytotoxic
Compounds. Bioorg. Med. Chem. 2001, 9, 607-612. (c) Wu, J. M.;
Shan, F.; Wu, G. S.; Li, Y.; Ding, J.; Xiao, D.; Han, J. X.; Atassi,
G.; Le´once, S.; Caignard, D. H.; Renard, P. Synthesis and Cytotox-
icity of Artemisinin Derivatives Containing Cyanoarylmethyl Group.
Eur. J. Med. Chem. 2001, 36, 469-479. (d) Pierre´, A.; Dunn, T. A.;
Kraus-Berthier, L.; Le´once, S.; Saint-Dizier, D.; Regnier, G.;
Dhainaut, A.; Bizzari, J. P.; Atassi, G. In Vitro and In ViVo
Circumvention of Multidrug Resistance by Servier 9788, a Novel
Triazinoaminopiperidine Derivative. I. InVest. New Drugs 1992, 10,
137-141. (e) Bojarski, C.; Gitter, A. H.; Bendfeldt, K.; Mankertz,
J.; Schmitz, H.; Wagner, S.; Fromm, M.; Schulzke, J. D. Permeability
of Human HT-29/B6 Colonic Epithelium as a Function of Apoptosis.
J. Physiol. 2001, 535, 541-552.
Supporting Information Available: X-ray crystallographic data
of 4a, cytotoxicity of 4a evaluated by the NCI, 1H NMR, 13C NMR,
and elemental analysis of all prepared compounds. This material
References
(1) Schepartz, S. A. Introduction and Historial Background. In Cancer
Chemotherapeutic Agents, 1st edition; Foye, W. O., Ed.; American
Chemical Society: Washington D.C., 1995; pp 1-7.
(2) (a) Doyle, T.-W. In Cancer and Chemotherapy; Crooke, S. T.,
Prestayko, A. W., Eds.; Academic Press: New York, 1980; Vol. 1,
pp 295-305. (b) Carter, S. K.; Bakowski, M. T.; Hellmann, K. In
Chemotherapy of Cancer, 3rd edition; John Wiley & Sons: New
York, 1987; pp 43-52. (c) Slichenmyer, W. J.; Rowinsky, E. K.;
Donehower, R. C.; Kaufmann, S. H. The Current Status of Camp-
tothecin Analogues as Antitumor Agents. J. Natl. Cancer Inst. 1993,
85, 271-278.
(3) (a) Sengupta, S. K. Topoisomerase II inhibitors. In Cancer Chemo-
therapeutic Agents; Foye, W. O., Ed.; American Chemical Society:
Washington, D. C., 1995; pp 246-250. (b) Foye, W. O.; Sengupta,
S. K. Cancer Chemotherapy. In Principles of Medicinal Chemistry;
Foye, W. O., Ed.; American Chemical Society: Washington, D. C.,
1995; chapter 37, pp 822-845. (c) Mosher, C. W.; Greus, O. P.;
Acton, E. M.; Goodman, L. Preparation and Antitumor Activity of
Olivacine and Some Analogs. J. Med. Chem. 1966, 9, 237-241. (d)
Kohn, K. W.; Waring, M. J.; Galubiger, D.; Friedman, C. A.
Intercalative Binding of Ellipticine to DNA. Cancer Res. 1975, 35,
71-76.
(4) (a) Jurayj, J.; Haugwitz, R. D.; Varma, R. K.; Paull, K. D.; Barret,
J. F.; Cushman, M. Design and Synthesis of Ellipticinium Salts and
1,2-Dihydroellipticines with High Selectivities against Human CNS
Cancers In Vitro. J. Med. Chem. 1994, 37, 2190-2197. (b) Sainsbury,
M. Ellipticines. In Chemistry of Antitumor Agents; Wilman, D. E.
V., Ed.; Chapman and Hall: New York, 1990; pp 410-435.
(5) (a) Auclair, C.; Pierre, A.; Voisin, E.; Pepin, O.; Cros, S.; Colas, C.;
Saucier, J. M.; Vershuere, B.; Gros, P.; Paoletti, C. Physicochemical
and Pharmacological Properties of the Antitumor Ellipticine Deriva-
tives 2-(2-Diethylaminoethyl)-9-hydroxyellipticinium Chloride, HCl.
Cancer Res. 1987, 47, 6254-6261. (b) Pierson, V.; Pierre, A.;
Pommier, Y.; Gros, P. Production of the Protein-Associated DNA
Breaks by 10-[Diethylaminopropylamino]-6-methyl-5H-pyrido[3′,4′:
4,5]pyrrolo[2,3-g]isoquinoline in Cultured L1210 Cells and in Isolated
Nuclei: Comparison with Other Topoisomerase II Inhibitors. Cancer
Res. 1988, 48, 1404-1409.
(6) (a) Tormo, J. R.; Estornell, E.; Gallardo, T.; Gonzalez, M. C.; Granell,
S.; Cortes, D.; Zafra-Polo, M. C. Gamma-Lactone-Functionalized
Antitumoral Acetogenins are the Most Potent Inhibitors of Mito-
chondrial Complex I. Bioorg. Med. Chem. Lett. 2001, 11, 681-684.
(b) Quintero, A.; Pelcastre, A.; Solano, J. D. Antitumoral Activity
of New Pyrimidine Derivatives of Sesquiterpene Lactones. J. Pharm.
Pharmaceut. Sci. 1999, 2, 108-112.
(7) (a) Zavala, F.; Guenard, D.; Robin, J.-P.; Brown, E. Structure-
Antitubulin Activity Relationships in Steganacin Congeners and
Analogs. Inhibition of Tubulin Polymerization In Vitro by (()-
Isodeoxypodophyllotoxin. J. Med. Chem. 1980, 23, 546-549. (b)
Beard, A. R.; Drew, M. G. B.; Hilgard, P.; Hudson, B. D.; Mann, J.;
Neidle, S.; Wong, L. F. T. Podophyllotoxin Analogs: Synthesis and
Computer Modeling Investigation of Structure-Activity Relation-
ships. Anticancer Drug Des. 1987, 2, 257-252.
(17) Experimental design and publicly available data (including the results
yacds/default.html.
(18) Le Pecq, J. B.; Dat-Xuong, N.; Gosse, C.; Paoletti, C. A New
Antitumoral Agent: 9-Hydroxyellipticine. Possibility of a Rational
Design of Anticancerous Drugs in the Series of DNA Intercalating
Drugs. Proc. Natl. Acad. Sci. U.S.A. 1974, 71, 5078-5082.
(19) (a) Spitzner, J. R.; Muller, M. T. A. Consensus Sequence for Cleavage
by Vertebrate DNA Topoisomerase II. Nucleic Acids Res. 1988, 16,
5533-5556. (b) Rowe, T. D.; Chen, G. L.; Hsuing, Y. H.; Liu, L.
H. Damage by Antitumor Acridines Mediated by Mammalian DNA
Topoisomerase II. Cancer Res. 1986, 46, 2021-2026.
(20) (a) Paull, K. D.; Lin, C. M.; Malspeis, L.; Hamel, E. Identification
of Novel Antimitotic Agents Acting at the Tubulin Level by
Computer-Assisted Evaluation of Differential Cytotoxicity Data.
Cancer Res. 1992, 52, 3892-3900. (b) Bai, R.; Paull, K. D.; Herald,
C. L.; Malspeis, L.; Petttit, G. R.; Hamel, E. Halichondrin B and
Homohalichondrin B, Marine Natural Products Binding in Vinca
(8) Terada, T.; Fujimoto, K.; Nomura, M.; Yamashita, J.; Wierzba, K.;
Yamazaki, R.; Shibata, J.; Sugimoto, Y.; Yamada, Y. Antitumor
Agents. 3. Synthesis and Biological Activity of 4â-Alkyl Derivatives
Containing Hydroxy, Amino, and Amido Groups of 4′-O-Demethyl-
4-desoxypodophyllotoxin as Antitumor Agents. J. Med. Chem. 1993,
36, 1689-1699.
(9) (a) Pujol, M. D.; Romero, M.; Sa´nchez, I. Synthesis and Biological
Activity of New Class of Dioxigenated Anticancer Agents. Curr.
Med. Chem.: Anti-Cancer Agents 2005, 5, 215-239. (b) Ruiz, N.;
Bouyssou, P.; Maurizis, J. C.; Madelmont, J. C.; Coudert, G.
Synthesis of a Benzodioxinic Analogue of Ellipticine and Evaluation
of its Antitumor Activity. Heterocycl. Commun. 1997, 3, 509-514.
(10) Ruiz, N.; Buon, C.; Pujol, M. D.; Guillaumet, G.; Coudert, C. Diels-
Alder Reactions of Furo[3,4-b]1,4-Benzodioxins: An Efficient
Approach to Substituted Dibenzo[b,e]1,4-dioxins. Synth. Commun.
1996, 26, 2057-2066.